358
Views
18
CrossRef citations to date
0
Altmetric
Review

Emergency contraception: A review

, &
Pages 9-16 | Published online: 06 Jul 2009

References

  • World Health Organization. Levonorgestrel for emergency contraception, WHO/RHR/Fact Sheet. WHO, Geneva October, 2005, Available at: www.who.int/reproductive-health/family_planning/ec.html (last accessed October 2007)
  • World Health Organization. Emergency Contraception: A guide for service delivery, WHO/FRH7FPP798.19. WHO, Geneva 1998, Available at: www.who.int (last accessed October 2007)
  • Trussell J, Rodriguez G, Ellerson C. Updated estimates of the effectiveness of the Yuzpe regimen of emergency contraception. Contraception 1999; 59: 147–151
  • Dixon G W, Schlesselman J J, Ory H W, Blye R P. Ethinyl estradiol and conjugated estrogens as postcoital contraceptives. JAMA 1980; 244: 323–330
  • Wilcox A J, Weinberg C R, Baird D D. Timing of sexual intercourse in relation to ovulation. Effects on the probability of conception, survival of the pregnancy, and sex of the baby. N Engl J Med 1995; 333: 1517–1521
  • Stirling A, Glasier A. Estimating efficacy of emergency contraception—How reliable are the data?. Contraception 2002; 66: 19–22
  • Yuzpe A A, Turlow H J, Ramzy I, Leyson J I. Post-coital contraception—A pilot study. J Reprod Med 1974; 30: 12–18
  • Hoffman K O. Postcoital contraception: Experiences with ethynil estradiol/norgestrel and levonorgestrel only. Proceedings of the XIth Congress on Fertility and Sterility, R F Harrison, J Bonnar, W Thompson. MTP Press Ltd, Lancaster 1984; 311–316
  • World Health Organization. Task Force on Post-Ovulatory Methods for Fertility Regulation, Special Programme for Research Training in Human Reproduction. Post coital contraception with levonorgestrel during the peri-ovulatory phase of the menstrual cycle. Contraception 1987; 36: 257–286
  • Task Force on Postovulatory Methods of Fertility Regulation. Randomized controlled trial of levonorgestrel versus the Yuzpe regimen of combined oral contraceptives for emergency contraception. Lancet 1998; 352: 428–433
  • von Hertzen H, Piaggio G, Ding J, et al. Low dose mifepristone and two regimens of levonorgestrel for emergency contraception: A WHO multicentre randomized trial. Lancet 2002; 360: 1803–1810
  • International Medical Advisory Panel, International Planned Parenthood Federation. IMAP statement on emergency contraception. IPPF Med Bull 2004; 38: 1–3
  • Cheng L, Gulmezolu A M, Oel C J, et al. Interventions for emergency contraception. Cochrane Database Syst Rev 2004, 3: CD 001324
  • Faculty of Family Planning and Reproductive Health Care Clinical Effectiveness Unit. FFPRHC guidelines. Emergency contraception. J Fam Plann Reprod Health Care 2006; 32: 121–128
  • Devoto L, Fuentes A, Palomino A, et al. Pharmacokinetics and endometrial tissue levels of levonorgestrel after administration of a single 1.5-mg dose by the oral and vaginal route. Fertil Steril 2005; 84: 46–51
  • Trussell J, Rodriguez G, Ellerston C. New estimates of the effectiveness of Yuzpe regimen for emergency contraception. Contraception 1998; 57: 363–369
  • Croxatto H B, Fuentealba B, Brache V, et al. Effects of the Yuzpe regimen, given during the follicular phase on ovarian function. Contraception 2002; 65: 121–128
  • Trussell J, Ellertson C, Dorflinger L. Effectiveness of the Yuzpe regimen of emergency contraception by cycle day of intercourse: implications for mechanism of action. Contraception 2003; 67: 167–171
  • Landgren B M, Johannisson E, Aedo A R, et al. The effect of levonorgestrel administered in large doses at different stages of the cycles on ovarian function and endometrial morphology. Contraception 1989; 39: 275–289
  • Kesseru E, Garmendia F, Westphal N, Parada J. The hormonal peripheral effects of dl-norgestrel in post-coital contraception. Contraception 1974; 10: 411–424
  • Yeung W SB, Chiu P CN, Wang C HYQ, et al. The effects of levonorgestrel on various sperm functions. Contraception 2002; 66: 453–457
  • Bahamondes L, Nascimento J AA, Munuce M J, et al. The in vitro effect of levonorgestrel on the acrosome reaction of human spermatozoa from fertile men. Contraception 2003; 68: 55–59
  • Gemzell-Danielsson K, Marions L. Mechanism of action of mifepristone and levonorgestrel when used for emergency contraception. Hum Reprod Update 2004; 10: 341–348
  • Durand M, Seppala M, Cravioto Mdel C, et al. Late follicular phase administration of levonorgestrel as an emergency contraceptive changes the secretory pattern of glycodelin in serum and endometrium during the luteal phase of the menstrual cycle. Contraception 2005; 71: 451–457
  • Christow A, Sun X, Gemzell-Daniellsson K. Effect of mifepristone and levonorgestrel on expression of steroid receptors in the human Fallopian tube. Mol Hum Reprod 2002; 8: 333–340
  • Durand M, Cravioto M C, Raymond E G, et al. On the mechanism of action of short-term levonorgestrel administration in emergency contraception. Contraception 2001; 64: 227–234
  • Croxatto H B, Devoto L, Durand M, et al. Mechanism of action of hormonal preparations used for emergency contraception: a review of the literature. Contraception 2001; 63: 111–121
  • Swahn M L, Westlund P, Johannisson E, Bygdeman M. Effect of post-coital contraceptive methods on the endometrium and the menstrual cycle. Acta Obstet Gynecol Scand 1996; 75: 738–744
  • Marions L, Hultenby K, Lindell I, et al. Emergency contraception with mifepristone and levonorgestrel: mechanism of action. Obstet Gynecol 2002; 100: 65–71
  • Croxatto H B. Pilules contraceptives d'urgence: Comment fonctionnent-elles?. IPPF Med Bull 2002; 36: 1–2
  • Ortiz M E, Ortiz R E, Fuentes M A, et al. Postcoital administration of levonorgestrel does not interfere with post-fertilization events in the new-world monkey Cebus apella. Hum Reprod 2004; 19: 1352–1356
  • Muller Al, Llados Cm, Croxatto H B. Postcoital treatment with levonorgestrel does not disrupt postfertilization events in the rat. Contraception 2003; 67: 415–419
  • FFPRHC Guidance. Drug interactions with hormonal contraception. J Fam Plann Reprod Health Care 2006; 31: 139–151
  • Verhoeven V, Peremans L, Avonts D, Van Royen P. The profile of emergency contraception users in a chlamydia prevalence study in primary care in Belgium. Eur J Contracept Reprod Health Care 2006; 11: 175–180
  • World Health Organization (WHO). Improving access to quality care in family planning. Medical eligibility criteria for contraceptive use, 3rd edn. WHO, Geneva 2004
  • Lahteemaki P, Heikinheimo O, Croxatto H, et al. Pharmacokinetics and metabolism of RU-486. J Steroid Biochem 1987; 27: 859–865
  • Carbonell Esteve J L, Garcia R, Breto A, Llorente M. Emergency contraception in Cuba with 10 mg of mifepristone. Eur J Contracept Reprod Health Care 2007; 12: 162–167
  • World Health Organization. Task Force on Post-ovulatory Methods for Fertility Regulation. Comparison of three single doses of mifepristone as emergency contraception: a randomized trial. Lancet 1999; 353: 697–702
  • von Hertzen H, Piaggio G, Ding J, et al. Low dose mifepristone and two regimens of levonorgestrel for emergency contraception: a WHO multicentre randomized trial. Lancet 2002; 360: 1803–1810
  • von Hertzen H, Piaggio G. Levonorgestrel and mifepristone in emergency contraception. Steroids 2003; 68: 1107–1113
  • van der Stege J G, Pahl-van Beest E H, Beerthuizen R JCM, et al. Effects of a preovulatory single low dose of mifepristone on ovarian function. Eur J Contracept Reprod Health Care 2006; 11: 104–108
  • Ashok P W, Stalder C, Wagaarachchi P T, et al. A randomized study comparing a low dose of mifepristone and the Yuzpe regimen for emergency contraception. Br J Obstet Gynaecol 2002; 109: 553–560
  • Lippes J, Malik T, Tatum H J. The post-coital copper-T. Adv Plann Parenth 1976; 11: 24–29
  • Zhou L, Xiao B. Emergency contraception with multiload Cu-375 SL IUD: A multicenter clinical trial. Contraception 2001; 64: 107–112
  • Ortiz M E, Croxatto H B. Mode of action of IUDs. Contraception 1987; 36: 37–53
  • Ortiz M E, Croxatto H B. Copper-T intrauterine device and levonorgestrel intrauterine system: Biological bases of their mechanism of action. Contraception 2007; 75: S16–30
  • Segal S J, Alvarez-Sanchez F, Adejuwon C A. Absence of chorionic gonadotropin among intrauterine device users: Detection of a highly sensitive assay. Fertil Steril 1987; 47: 265–269
  • Farley T MN, Rosenberg M J, Rose P J, et al. Intrauterine devices and pelvic inflammatory disease: An international perspective. Lancet 1992; 339: 785–788
  • Mandiracioglu A, Mevsim V, Turgul O. Health personnel perceptions about emergency contraception in primary health-care centers. Eur J Contracept Reprod Health Care 2003; 8: 145–149
  • Lete I, Cabero L, Alvarez D, Olle C. Observational study on the use of emergency contraception in Spain: Results of a national survey. Eur J Contracept Reprod Health Care 2003; 8: 203–209
  • Zeteroglu S, Sahin G, Sahin H A, Bolluk G. Knowledge and attitudes towards emergency contraception of health-care providers in a region with a high birth rate. Eur J Contracept Reprod Health Care 2004; 9: 102–106
  • Jones S. Emergency contraception use by Irish teenagers. Eur J Contracept Reprod Health Care 2005; 10: 26–28
  • Uzuner A, Ünalan P, Akman M, et al. Providers' knowledge of, attitude to and practice of emergency contraception. Eur J Contracept Reprod Health Care 2005; 10: 43–50
  • Bildircin M, Sahin N H. Knowledge, attitudes and practices regarding emergency contraception among family-planning providers in Turkey. Eur J Contracept Reprod Health Care 2005; 10: 151–156
  • Bastianelli C, Farris M, Benagiano G. Reasons for requesting emergency contraception: A survey of 506 Italian women. Eur J Contracept Reprod Health Care 2005; 10: 157–163
  • Celik M, Ekerbicer H C, Ergun U G, Tekin N. Emergency contraception: Knowledge and attitudes of Turkish nursing and midwifery students. Eur J Contracept Reprod Health Care 2007; 12: 63–69
  • , et al. Consensus statement on emergency contraception. Contraception 1995; 52: 211–213
  • Jackson R A, Bimla Schwarz E, Freedman L, Darney P. Advance supply of emergency contraception: effect on use and usual contraception—A randomized trial. Obstet Gynecol 2003; 102: 8–16
  • Gold M A, Wolford J E, Smith K A, Parker A M. The effects of advance provision of emergency contraception on adolescent women's sexual and contraceptive behaviors. J Pediatr Adolesc Gynecol 2004; 17: 87–96
  • Belzer M, Sanchez K, Olson J, et al. Advance supply of emergency contraception: a randomized trial in adolescent mothers. J Pediatr Adolesc Gynecol 2005; 18: 347–354
  • Raine T R, Harper C C, Rocca C H, et al. Direct access to emergency contraception through pharmacies and effect on unintended pregnancy and STIs: a randomized controlled trial. JAMA 2005; 293: 54–62
  • Lo S S, Fan S Y, Ho P C, Glasier A F. Effect of advanced provision of emergency contraception on women's contraceptive behaviour: a randomized controlled trial. Hum Reprod 2004; 19: 2404–2410
  • Brandt D. Emergency contraception for teens and young women: researchers find that it doesn't inhibit contraceptive use or increase rates of sexually transmitted infections. Am J Nurs 2005; 105: 21
  • Marston C, Meltzer H, Majeed A. Impact on contraceptive practice of making emergency hormonal contraception available over the counter in Great Britain: repeated cross sectional surveys. BMJ 2005; 331: 271
  • Gainer E, Blum J, Toverud E L, et al. Bringing emergency contraception over the counter: experiences of nonprescription users in France, Norway, Sweden and Portugal. Contraception 2003; 68: 117–124
  • Ziebland S, Wyke S, Seaman P, et al. What happened when Scottish women were given advance supplies of emergency contraception? A survey and qualitative study of women's views and experiences. Soc Sci Med 2005; 60: 1767–1779
  • Larsson M, Aneblom G, Eurenius K, et al. Limited impact of an intervention regarding emergency contraceptive pills in Sweden—repeated surveys among abortion applicants. Eur J Contracept Reprod Health Care 2006; 11: 270–276

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.